Search Results 1121-1130 of 10295 for total t4
The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS) ...
... complete resection. Patient Adherence and Symptoms During Post-operative Fluid Restriction Protocol After Transsphenoidal Surgery. Jacksonville, Fla. The ...
... Total Body Irradiation (Cy/TBI) Cyclophosphamide (120 mg/kg) TBI (1200-1420 cGy). • Recovery of counts by day 42 and able to start midostaurin by day 60 post ...
... overall exercise capacity and exertional symptoms through improvement in cardiac output via stroke volume. We hypothesize that patients enrolled in HIIT ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Primary Endpoint is Overall Survival. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
Patients who complete the initial treatment stage of up to 16 cycles may be eligible for MPDL3280A re-treatment upon subsequent disease progression during ...
... complete four study visits. Your first two study visits as described above will be completed at the beginning of cardiac rehabilitation and then we will ask ...
The purpose of this study is to evaluate the effectiveness of cilta-cel OOS based on overall response of partial response (PR) or better (overall response rate, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.